Bettina Wiese

OE 6300, Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumors.

Germline variants in ATM, BRCA2, other cancer predisposition and novel candidate genes are implicated in glioma risk in adult glioma patients with a familial or personal history of tumors.

Journal: Acta neuropathologica

Published: August 26, 2025

Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families.

Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families.

Journal: Acta neuropathologica communications

Published: August 23, 2023

Moderately Hypofractionated Radio(chemo)therapy With Simultaneous Integrated Boost for Recurrent, Previously Irradiated, High-grade Glioma.

Moderately Hypofractionated Radio(chemo)therapy With Simultaneous Integrated Boost for Recurrent, Previously Irradiated, High-grade Glioma.

Journal: Anticancer research

Published: February 11, 2023

Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the NF2:c.784C>T p.(Arg262*) variant.

Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the NF2:c.784C>T p.(Arg262*) variant.

Journal: Clinical neuropathology

Published: April 21, 2022

The Emesis Trial: Depressive Glioma Patients Are More Affected by Chemotherapy-Induced Nausea and Vomiting.

The Emesis Trial: Depressive Glioma Patients Are More Affected by Chemotherapy-Induced Nausea and Vomiting.

Journal: Frontiers in neurology

Published: September 09, 2021

Primary and secondary gliosarcoma: differences in treatment and outcome.

Primary and secondary gliosarcoma: differences in treatment and outcome.

Journal: British journal of neurosurgery

Published: February 04, 2021

Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.

Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.

Journal: Acta neuropathologica

Published: January 26, 2021

Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.

Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.

Journal: Acta neuropathologica

Published: June 21, 2017

Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme.

Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme.

Journal: American journal of clinical oncology

Published: April 13, 2012

Malignant glioma grade 3 and 4: how relevant is timing of radiotherapy?

Malignant glioma grade 3 and 4: how relevant is timing of radiotherapy?

Journal: Clinical neurology and neurosurgery

Published: November 11, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026